Form 8-K - Current report:
SEC Accession No. 0000950170-24-127004
Filing Date
2024-11-14
Accepted
2024-11-14 16:00:09
Documents
13
Period of Report
2024-11-14
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K cue-20241114.htm   iXBRL 8-K 56640
2 EX-99.1 cue-ex99_1.htm EX-99.1 135772
3 GRAPHIC img239719762_0.jpg GRAPHIC 3259
  Complete submission text file 0000950170-24-127004.txt   345207

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cue-20241114.xsd EX-101.SCH 44884
15 EXTRACTED XBRL INSTANCE DOCUMENT cue-20241114_htm.xml XML 4511
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Filer) CIK: 0001645460 (see all company filings)

EIN.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38327 | Film No.: 241461381
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)